Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.
about
Association of genotypes with infection types and antifungal susceptibilities in Candida albicans as revealed by recent molecular typing strategiesCell wall mannan and cell surface hydrophobicity in Candida albicans serotype A and B strains.Applications of flow cytometry to clinical microbiology.The ins and outs of DNA fingerprinting the infectious fungiCytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans.Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected womenRelatedness analyses of Histoplasma capsulatum isolates from Mexican patients with AIDS-associated histoplasmosis by using histoplasmin electrophoretic profiles and randomly amplified polymorphic DNA patterns.Species and genotypic diversities and similarities of pathogenic yeasts colonizing women.Multilocus genotyping indicates that the ability to invade the bloodstream is widespread among Candida albicans isolatesComparison of salivary Candida profile in patients with fixed and removable orthodontic appliances therapyExpression of Candida albicans SAP1 and SAP2 in experimental vaginitis.Antibody response that protects against disseminated candidiasisElevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.Gamma interferon is not essential in host defense against disseminated candidiasis in miceTyping tools for the investigation of epidemic fungal infection.Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus.Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers.Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patientsTyping Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.Candida albicans serotype analysis by flow cytometry.Candida albicans strain delineationMapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies.Properties of a rat monoclonal antibody reactive with both the mannan of Candida species and the O-antigen 6,7 polysaccharide of serogroup C1 salmonellaeEvidence for expression of the C3d receptor of Candida albicans in vitro and in vivo obtained by immunofluorescence and immunoelectron microscopyAdherence and receptor relationships of Candida albicansGenetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprintingCoaggregation of oral Candida isolates with bacteria from bone marrow transplant recipientsCandida albicans biotypes in human immunodeficiency virus type 1-infected patients with oral candidiasis before and after antifungal therapy.Comparison between methods for serotyping of Candida albicans produces discrepancies in resultsBeta-1,2-mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype.Serotype prevalence of Candida albicans from blood culture isolates.Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces
P2860
Q27023720-E058689E-1BF8-4B98-8042-B686B5C33C3EQ30434895-AAFA250E-E0A1-4A33-9A57-7E36B1811FBAQ33555394-A9735519-163F-4F3B-8C1E-A35EC050DEB6Q33555593-2F08713A-9A4D-4257-B98B-57600A91E9EFQ33610085-706FFE3C-7C98-4155-A22F-9E45B3A47B41Q33675896-86C533A1-48BE-40A5-83BB-C841755CBF0CQ33960136-19DA7D12-F2EA-4CD3-8E53-8B7C51BEAD9AQ33960167-D4FA445B-79CB-4D21-9BE0-D2B745B3FE85Q33964060-0ADDFFDA-398A-4A2D-B412-6B0457F960BDQ33972089-BF451E7A-24F8-471E-A00A-DE4D07E112A1Q35201267-334A03B9-EC6B-4146-BC9C-6019B09EBEE6Q35410834-50AB085F-8EC6-468F-B9DA-8F3951B80838Q35424332-AB886A7E-218D-46B4-A37E-B411D50267E4Q35467162-E48BFA14-A22C-4B16-8B61-12FA76CA3A3BQ35546571-2A1702E7-3C93-472E-829B-288B7FC263A0Q36504987-1FC30065-C366-4FC6-A4D4-741955638946Q36519689-EB0CE5FE-A386-482B-89DC-E936AB29DD34Q36521881-3182656A-3CE1-4A22-B8B3-5FAB1651114EQ36525223-565947FE-C2D0-4582-9740-649F33AB0B51Q36532735-2B5033FC-FD98-4FDB-85C8-455FDDE3C035Q36537515-B08C9A16-E7A8-4AB2-AD46-BEB89CD3A676Q36636523-3A077916-0A97-49EC-92CB-5CB2F62EC133Q36950859-75A1E4D8-57C4-4156-BF7F-B7013259339CQ36959525-4CE585B8-8E38-41FE-B4DA-C69FF46BC8F6Q36963817-FD129C86-E460-4F76-9FB9-CF710DCF3C1FQ37056722-9CA508F8-1F12-47F5-BFE6-3D4DC7827BF7Q37118999-6AE26CB1-D75A-4E12-B15F-D963691490FCQ37193145-87C50F58-91CE-4004-99A0-C10A99F6F68CQ37233028-E776CC44-1322-47C9-A2F0-5452BD2F2E09Q37234720-87645424-2E06-46D2-9847-8EA4D1881241Q39656060-00FB05E4-62ED-40D6-94CC-14BD8DA03CE6Q40185025-E09C2960-8641-4246-A136-8B3D8B394176Q40720243-401ED8CC-AD7C-4480-9E9D-235C16254AD9
P2860
Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1989
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral Candida albicans isolates ...... red immunodeficiency syndrome.
@en
Oral Candida albicans isolates ...... red immunodeficiency syndrome.
@nl
type
label
Oral Candida albicans isolates ...... red immunodeficiency syndrome.
@en
Oral Candida albicans isolates ...... red immunodeficiency syndrome.
@nl
prefLabel
Oral Candida albicans isolates ...... red immunodeficiency syndrome.
@en
Oral Candida albicans isolates ...... red immunodeficiency syndrome.
@nl
P2860
P1476
Oral Candida albicans isolates ...... red immunodeficiency syndrome.
@en
P2093
D L Brawner
J E Cutler
P2860
P304
P407
P577
1989-06-01T00:00:00Z